Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) in Preventing HIV-1 Infections in Rural Zambia: A Modeling Study

BACKGROUND: Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine effectively prevents new HIV infections. The optimal scenario for implementing PrEP where most infections are averted at the lowest cost is unknown. We determined the impact of different PrEP strategies on averting new infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Nichols, Brooke E., Boucher, Charles A. B., van Dijk, Janneke H., Thuma, Phil E., Nouwen, Jan L., Baltussen, Rob, van de Wijgert, Janneke, Sloot, Peter M. A., van de Vijver, David A. M. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601101/
https://www.ncbi.nlm.nih.gov/pubmed/23527217
http://dx.doi.org/10.1371/journal.pone.0059549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601101/
https://www.ncbi.nlm.nih.gov/pubmed/23527217
http://dx.doi.org/10.1371/journal.pone.0059549

Ejemplares similares